title: Exploration of Sitagliptin as a potential inhibitor for the M1 Alanine aminopeptidase enzyme in Plasmodium falciparum using computational docking.
abstract: Plasmodium falciparum has limited capacity for de novo amino acid synthesis and rely on degradation of host hemoglobin to maintain protein metabolism and synthesis of proteins. M1 alanine aminopeptidase enzyme of the parasite involved in the terminal degradation of host hemoglobin was subjected to in silico screening with low molecular weight protease inhibitors. The km (avg) of the enzyme M1 alanine aminopeptidase for the substrate DL - Alanine β Napthylamide Hydrochloride was estimated as 322.05µM. The molecular interactions between the enzyme and the substrate and the mechanism of enzyme action were analyzed which paved way for inhibition strategies. Among all the inhibitors screened, Sitagliptin was found to be most potent inhibitor with ki of 0.152 µM in its best orientation whereas the ki(avg) was 2.0055 µM. The ki of Sitagliptin is lower than the km of M1 alanine aminopeptidase for the substrate DL - Alanine β Napthylamide Hydrochloride (322.05 µM) and Ki of the known inhibitor Bestatin. Therefore Sitagliptin may serve as a potent competitive inhibitor of the enzyme M1 alanine aminopeptidase of Plasmodium falciparum.
authors.affiliation: Department of Biotechnology, Kamaraj College of Engineering and Technology, Virudhunagar.
authors.forename: Mohana
authors.initials: M
authors.lastname: Krishnamoorthy
authors.forename: Anant
authors.initials: A
authors.lastname: Achary
keywords: Bestatin; Computational Docking; DL – Alanine β Napthylamide Hydrochloride; M1 alanine aminopeptidase; Plasmodium falciparum; Sitagliptin
references.citation: Chem Biol. 2008 Sep 22;15(9):920-9
references.pmid: 18804029
references.citation: Eur J Biochem. 1995 Aug 1;231(3):528-34
references.pmid: 7649151
references.citation: Mol Biochem Parasitol. 2001 Sep 28;117(1):37-48
references.pmid: 11551630
references.citation: J Mol Biol. 1982 Oct 5;160(4):623-39
references.pmid: 7175940
references.citation: Proc Natl Acad Sci U S A. 2006 Sep 5;103(36):13339-44
references.pmid: 16938892
references.citation: J Biol Chem. 2009 Apr 17;284(16):10618-26
references.pmid: 19228697
references.citation: Nat Struct Biol. 2001 Feb;8(2):131-5
references.pmid: 11175901
references.citation: J Biol Chem. 2006 Jan 20;281(3):1741-5
references.pmid: 16286469
references.citation: Pharmacol Ther. 2003 Aug;99(2):221-60
references.pmid: 12888113
references.citation: J Biol Chem. 1991 Aug 5;266(22):14294-9
references.pmid: 1907277
references.citation: J Biol Chem. 2004 Oct 8;279(41):43000-7
references.pmid: 15304495
references.citation: Curr Top Microbiol Immunol. 2005;295:275-91
references.pmid: 16265895
references.citation: Biochem J. 1997 Nov 1;327 ( Pt 3):883-9
references.pmid: 9581570
references.citation: J Biol Chem. 2006 Nov 3;281(44):33664-76
references.pmid: 16885166